InterConnect seeks to optimise the use of existing data to enable new research into the causes of diabetes and obesity.
The variation in the risk of diabetes and obesity between different countries and continents around the world is considerably greater than the variation in risk within individual countries. This population level heterogeneity in diet, physical activity and disease outcomes is largely unexplained because physically bringing data together from cohort studies across the world is constrained by governance, ethical and legal challenges.
To address this, InterConnect is taking a new approach to enabling cross-cohort analyses. Rather than physically bringing the data together for analysis, it is ‘taking the analysis to the data’.
What’s happening? Register here for the pre-EASD InterConnect Symposium on 12 September in Munich